M F Brady

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.

G.J.S. Rustin, Ann E. Nelstrop, Patrick McClean et al. · Journal of Clinical Oncology · 1996 · 377 citations

Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study.

D Barnhill, R. J. Kurman, M F Brady et al. · Journal of Clinical Oncology · 1995 · 171 citations

Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).

William P. McGuire, W.J. Hoskins, M F Brady et al. · PubMed · 1996 · 152 citations

Advanced epithelial ovarian cancer: 1998 consensus statements

J. S. Berek, K. Bertelsen, Andreas du Bois et al. · Annals of Oncology · 1999 · 85 citations · Full text

Gynecological Surgery, Medicine, Gynecology +4

Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study.

William P. McGuire, W.J. Hoskins, M F Brady et al. · PubMed · 1997 · 31 citations